Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL449126 | 0.70 | ATM (0.46) | ATMALDH1A1GLAMAPTHPGD | |
| SCHEMBL24772 | 0.67 | ATM (0.43) | ATMACHENPC1RAB9A | |
| SCHEMBL51544 | 0.65 | ATM (0.41) | ATMNPC1RAB9A | |
| SCHEMBL253244 | 0.65 | ATM (0.41) | ATMACHENPC1RAB9A | |
| SCHEMBL51581 | 0.65 | ATM (0.41) | ATMNPC1RAB9A | |
| Hydrochloric Acid SCHEMBL10501335 | 0.64 | ATM (0.40) | ATMACHENPC1RAB9A | |
| SCHEMBL9477126 | 0.63 | ATM (0.48) | ATMALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL8424490 | 0.63 | ATM (0.48) | ATMNPC1RAB9A | |
| SCHEMBL4559941 | 0.63 | ATM (0.48) | ATMNPC1RAB9A | |
| SCHEMBL3535166 | 0.63 | ATM (0.48) | ATMMAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3160517-B1 | WATER-SOLUBLE ACTIVATABLE MOLECULAR PROBES, INTERMEDIATES FOR THE SYNTHESIS THEREOF AND ASSOCIATED DETECTION METHODS | ECOLE NORMALE SUPERIEURE LYON (FR) | 2024-06-12 | — | — | EP | claimed |
| EP-3555112-B1 | FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION METHOD | ECOLE NORMALE SUPERIEURE LYON (FR) | 2023-12-06 | — | — | EP | claimed |
| EP-3555112-A1 | FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION METHOD | Ecole Normale Superieure De Lyon (FR) | 2019-10-23 | — | — | EP | claimed |
| US-10179929-B2 | Water-soluble activatable molecular probes, intermediates for the synthesis thereof and associated detection methods | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2019-01-15 | — | — | US | claimed |
| EP-2760844-B1 | FLUOROGENIC PEPTIDASE SUBSTRATE | ECOLE NORMALE SUPERIEURE LYON (FR) | 2018-11-21 | — | — | EP | claimed |
| US-20170159100-A1 | WATER-SOLUBLE ACTIVATABLE MOLECULAR PROBES, INTERMEDIATES FOR THE SYNTHESIS THEREOF AND ASSOCIATED DETECTION METHODS | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2017-06-08 | — | — | US | claimed |
| US-9605296-B2 | Fluorogenic peptidase substrate | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2017-03-28 | — | — | US | claimed |
| US-9593362-B2 | Fluorogenic glycosidase substrate and associated detection method | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2017-03-14 | — | — | US | claimed |
| EP-2880045-B1 | FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION PROCESS | Ecole Normale Supérieure de Lyon (FR) | 2016-07-20 | — | — | EP | claimed |
| US-20150299762-A1 | FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION METHOD | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2015-10-22 | — | — | US | claimed |
| EP-0700904-B1 | Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic as well as medicaments containing them | HOECHST AG (DE) | 2001-12-05 | — | — | EP | claimed |
| EP-0794955-B1 | HINDERED N-OXIDE ESTERS OF RAPAMYCIN AND THEIR USE AS MEDICAMENTS | AMERICAN HOME PROD (US) | 2001-07-25 | — | — | EP | claimed |
| US-5559122-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-09-24 | — | — | US | claimed |
| US-5521194-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-05-28 | — | — | US | claimed |
| US-5508290-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-04-16 | — | — | US | claimed |
| US-5508285-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-04-16 | — | — | US | claimed |
| US-5491231-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-02-13 | — | — | US | claimed |
| EP-0584222-A4 | BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE | RHONE POULENC RORER INT (US) | 1994-07-06 | — | — | EP | claimed |
| EP-0584222-A1 | BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE. | RHONE POULENC RORER INT (US) | 1994-03-02 | — | — | EP | claimed |
| WO-1992020642-A1 | BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-11-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10179929-B2 | Water-soluble activatable molecular probes, intermediates for the synthesis thereof and associated detection methods | SI, GUSB, ABCG2 | ATM 4251/4885ALDH1A1 426/4885GLA 51/4885 |
| US-20170159100-A1 | WATER-SOLUBLE ACTIVATABLE MOLECULAR PROBES, INTERMEDIATES FOR THE SYNTHESIS THEREOF AND ASSOCIATED DETECTION METHODS | SI, GUSB, ABCG2 | ATM 4251/4885ALDH1A1 426/4885GLA 51/4885 |
| US-20150299762-A1 | FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION METHOD | MAN2B1, FUCA1, NEU1 | ATM 4875/4885ALDH1A1 200/4885GLA 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.